Connecticut § 19a-591b Immunity from liability for civil damages for personal injury to research subject. Exceptions.

Connecticut Statutes

§ 19a-591b — Immunity from liability for civil damages for personal injury to research subject. Exceptions.

Connecticut § 19a-591b

Title 19aPublic Health and Well-Being

Ch. 368xAIDS Testing and Medical Information

This text of Connecticut § 19a-591b (Immunity from liability for civil damages for personal injury to research subject. Exceptions.) is published on Counsel Stack Legal Research, covering Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Conn. Gen. Stat. § 19a-591b (2026).

Text

A manufacturer, research institution or researcher shall not be liable to a research subject for civil damages for personal injury resulting from the administration of any AIDS vaccine to such research subject, unless such injury was caused by the gross negligence or reckless, wilful or wanton misconduct of such manufacturer, research institution or researcher or such manufacturer, research institution or researcher has failed to comply with the provisions of section 19a-591a. The immunity provided by this section shall not apply to a manufacturer, research institution or researcher who intentionally provided false information in connection with an investigational new drug application.

Free access — add to your briefcase to read the full text and ask questions with AI

A manufacturer, research institution or researcher shall not be liable to a research subject for civil damages for personal injury resulting from the administration of any AIDS vaccine to such research subject, unless such injury was caused by the gross negligence or reckless, wilful or wanton misconduct of such manufacturer, research institution or researcher or such manufacturer, research institution or researcher has failed to comply with the provisions of section 19a-591a. The immunity provided by this section shall not apply to a manufacturer, research institution or researcher who intentionally provided false information in connection with an investigational new drug application.